GCG and Dravet syndrome: In the current study, we have shown that GLP-1 (9-36), a natural peptide and the primary cleavage product of the incretin hormone GLP-1 (7-36), ameliorates cognitive deficits and synaptic plasticity impairments in a mouse model of DS.